JP2000053696A - Hydrolyzed poriferan protein and its production - Google Patents

Hydrolyzed poriferan protein and its production

Info

Publication number
JP2000053696A
JP2000053696A JP11010702A JP1070299A JP2000053696A JP 2000053696 A JP2000053696 A JP 2000053696A JP 11010702 A JP11010702 A JP 11010702A JP 1070299 A JP1070299 A JP 1070299A JP 2000053696 A JP2000053696 A JP 2000053696A
Authority
JP
Japan
Prior art keywords
protein
sponge
solution
hydrolase
raw material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11010702A
Other languages
Japanese (ja)
Other versions
JP3094090B2 (en
Inventor
Kenji Nakamura
憲司 中村
Koji Nakamura
興司 中村
Takeshi Okada
猛 岡田
Tadao Miyake
忠雄 三宅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP11010702A priority Critical patent/JP3094090B2/en
Publication of JP2000053696A publication Critical patent/JP2000053696A/en
Application granted granted Critical
Publication of JP3094090B2 publication Critical patent/JP3094090B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Fodder In General (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Feed For Specific Animals (AREA)

Abstract

PROBLEM TO BE SOLVED: To effectively utilize dried poriferan sponge which is a scrap of sponge used for body-cleaning or make-up and hitherto discarded as a waste. SOLUTION: The objective hydrolyzed poriferan protein is produced by dissolving a porifer and neutralizing the supernatant of the solution or further treating the obtained poriferan protein solution with a proteinase. A functional low-molecular peptide and/or amino acid produced by treating the hydrolyzed poriferan protein with an ultrafiltration membrane, precision filtration membrane, gel-filtration membrane or ion-exchange resin are used as a food raw material, a raw material for pet food, cosmetics, pharmaceuticals or an agent having proliferation promoting action on the cells originated from mammalian.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、乾燥海綿動物を溶
解させた後、上澄み液を中和して得られる、食品用原
料、ペットフ−フド用原料、化粧品又は医薬品並びに哺
乳類由来の細胞に対して増殖促進作用を有する用途に供
する海綿動物タンパク質溶液に関する。また、本発明
は、乾燥海綿動物を溶解させた後、上澄み液を中和して
得られた海綿動物タンパク質溶液にタンパク質加水分解
酵素を作用させて得られる、食品用原料、ペットフ−フ
ド用原料、化粧品又は医薬品並びに哺乳類由来の細胞に
対して増殖促進作用を有する用途に供する海綿動物タン
パク質加水分解物とその製造方法に関する。また、本発
明は、乾燥海綿動物を溶解させた後、上澄み液を中和し
て得られた海綿動物タンパク質溶液にタンパク質加水分
解酵素を作用させて得られる海綿動物タンパク質加水分
解物を限外濾過膜、精密濾過膜、ゲル濾過又はイオン交
換樹脂を用いて精製することによって得られる、食品用
原料、ペットフ−フド用原料、化粧品又は医薬品並びに
哺乳類由来の細胞に対して増殖促進作用を有する用途に
供する得られる機能性低分子ペプチド及び/又はアミノ
酸とその製造方法に関する。
The present invention relates to a food material, a pet food material, a cosmetic or pharmaceutical, and a cell derived from a mammal obtained by dissolving a dried sponge and then neutralizing the supernatant. The present invention relates to a sponge protein solution for use in applications having a growth promoting action. In addition, the present invention provides a raw material for food and a raw material for pet food obtained by dissolving a dried sponge and then neutralizing the supernatant to obtain a protein solution of the sponge, which is then reacted with a protein hydrolase. The present invention relates to a sponge protein hydrolyzate for use in cosmetics, pharmaceuticals, and applications having a growth-promoting effect on mammalian cells, and a method for producing the same. In addition, the present invention provides a method for ultrafiltration of a sponge protein hydrolyzate obtained by allowing a protein hydrolase to act on a sponge protein solution obtained by dissolving a dried sponge and then neutralizing the supernatant. Membrane, microfiltration membrane, gel filtration or purification by using ion exchange resin, for use in foods, pet foods, cosmetics or pharmaceuticals, and in applications that have a growth promoting effect on mammalian cells The present invention relates to a functional low-molecular peptide and / or amino acid to be provided and a method for producing the same.

【0002】[0002]

【従来の技術】従来、畜肉類では屠殺時に出てくる血
液、あるいは魚介類ではステックウォーター、魚肉水晒
し廃液濃縮物、缶詰製造時に生じる煮汁など、通常は廃
棄されるものから有用なタンパク質を分離・精製する試
みがなされてきた。しかし、繊維性のスポンジである、
海綿動物からのタンパク質の有効利用に関する情報は全
く知られていない。海綿動物は、従来より身体の洗浄用
や化粧用などのスポンジとして使用され、現在も高級ス
ポンジとして愛用されている。その理由は、海綿動物が
水吸収性に富み、且つ他の天然及び合成スポンジに比べ
て皮膚に対する感触が非常に良いためであるが、洗浄用
や化粧用など以外の分野にはほとんど有効利用されてい
ないのが現状である。また、上記のスポンジとして利用
される部分については、有用な用途が見つからず、破棄
処分とせざるをえなかった。これら、海綿スポンジとし
て使用される繊維性の物質の成分を分析すると、水分以
外はほとんどがタンパク質であり、しかもそのタンパク
質のアミノ酸分析を行うと、グリシン、アスパラギン
酸、グルタミン酸、プロリン、アルギニンなどの有用な
アミノ酸を多く含んでいることがわかったが、未だ有益
な利用用途は見つかっていない。
2. Description of the Related Art Conventionally, useful proteins are separated from those normally discarded, such as blood coming out at the time of slaughter for animal meat, or stick water, fish water-exposed waste liquid concentrate, and broth produced during canning for fish and shellfish. -Attempts to purify have been made. However, it is a fibrous sponge,
No information on the effective use of proteins from sponges is known. Sponge animals have conventionally been used as sponges for washing and makeup of the body, and are still favored as high-grade sponges. The reason is that sponges are rich in water absorption and have a very good skin feel compared to other natural and synthetic sponges, but they are almost effectively used in fields other than cleaning and cosmetics. It is not at present. Further, for the portion used as the above-mentioned sponge, a useful use was not found, and it had to be discarded. When analyzing the components of these fibrous substances used as sponge sponges, most of them are proteins except for water, and amino acid analysis of the proteins reveals the usefulness of glycine, aspartic acid, glutamic acid, proline, arginine, etc. It has been found to contain a lot of unique amino acids, but no useful use has yet been found.

【0003】[0003]

【発明が解決しようとする課題】本発明者らは、海綿動
物の有効利用、例えば生理活性や呈味性の高いタンパク
質加水分解物を製造し得る方法について鋭意研究した結
果、繊維性の海綿動物に含まれるタンパク質をアルカリ
溶液、酸性溶液、あるいはタンパク質加水分解酵素で溶
解させることによって、生理活性及び呈味性の高い性質
をもつタンパク質加水分解物を製造できることを見い出
し、本発明に至った。即ち、本発明で、乾燥海綿動物を
溶解させた後、上澄み液を中和して得られた海綿動物タ
ンパク質溶液自体、及び上澄み液を中和して得られた海
綿動物タンパク質溶液にタンパク質加水分解酵素を作用
させて得られる海綿動物タンパク質加水分解物がきわめ
て生理活性及び呈味性の高い性質を有し、食品用原料、
ペットフ−フド用原料、化粧品又は医薬品並びに哺乳類
由来の細胞に対して増殖促進作用を有する用途に供する
ことのできることを発見した。さらに、このようにして
得られたタンパク質加水分解物を追加的に限外濾過膜、
精密濾過膜、ゲル濾過、あるいはイオン交換樹脂によっ
て精製分離した得られた機能性低分子ペプチド及びアミ
ノ酸も、タンパク質加水分解物同様に食品用原料、ペッ
トフ−フド用原料、化粧品又は医薬品及び哺乳類由来の
細胞に対して増殖促進作用を有することをも見いだすこ
とができた。
DISCLOSURE OF THE INVENTION The present inventors have conducted intensive studies on the effective use of sponges, for example, a method of producing a protein hydrolyzate having high physiological activity and taste. It has been found that a protein hydrolyzate having high physiological activity and high taste can be produced by dissolving the protein contained in E. coli with an alkaline solution, an acidic solution or a protein hydrolase. That is, in the present invention, after dissolving a dried sponge, the sponge protein solution itself obtained by neutralizing the supernatant and the sponge protein solution obtained by neutralizing the supernatant are proteolytically hydrolyzed. The sponge protein hydrolyzate obtained by the action of an enzyme has extremely high physiological activity and taste, and is a raw material for food,
It has been discovered that it can be used for pet food materials, cosmetics or pharmaceuticals, and for applications having a growth promoting action on mammalian cells. Further, the protein hydrolyzate thus obtained is additionally subjected to an ultrafiltration membrane,
Functional low molecular peptides and amino acids obtained by purification and separation by microfiltration membrane, gel filtration, or ion-exchange resin are also used as raw materials for foods, raw materials for pet food, cosmetics or pharmaceuticals and mammals as well as protein hydrolysates. It has also been found that the cells have a growth promoting effect on cells.

【0004】[0004]

【課題を解決するための手段】本発明による海綿動物タ
ンパク質溶解物の製造方法は、海中に生息している海綿
動物を乾燥させた原料に、水酸化ナトリウム、水酸化カ
リウム、水酸化カルシウム、水酸化マグネシウムのよう
なアルカリ希釈溶液、好ましくは0.01〜50重量%
のものを加えて、十分に溶解するまで攪拌する。又は、
乾燥原料に塩酸、硫酸、硝酸、蟻酸、酢酸のような酸性
高濃度溶液、好ましくは0.01〜50重量%のものを
加えて、十分に溶解するまで攪拌する。上記アルカリ溶
解あるいは酸性溶解ともに溶解を促進させるために加温
するのが効率的である。次いで、上記繊維性海綿の溶解
後、中和し、不溶物は遠心分離や濾過布などで除去す
る。引き続き、濾液を活性炭処理して異臭や褐色の色を
除去する。この段階で、清澄な粘性のある海綿動物タン
パク質溶解物が得られる。さらに得られたタンパク質溶
解物を精製する場合には、硫酸アンモニウムのような塩
析沈殿、エチルアルコール、メチルアルコールやアセト
ンのような有機溶媒による沈殿、ゲル濾過処理、イオン
交換樹脂処理などを行う。このように得られた海綿由来
のタンパク質溶解物は、食品用原料、ペツトフード用原
料、化粧品・医薬品原料などの幅広い分野で使用できる
ことがわかった。
According to the present invention, there is provided a method for producing a lysate of sponge protein, comprising the steps of adding sodium hydroxide, potassium hydroxide, calcium hydroxide, water Alkali diluted solution such as magnesium oxide, preferably 0.01 to 50% by weight
And stir until well dissolved. Or
A highly acidic solution such as hydrochloric acid, sulfuric acid, nitric acid, formic acid or acetic acid, preferably 0.01 to 50% by weight, is added to the dry raw material, and the mixture is stirred until it is sufficiently dissolved. It is efficient to heat both the alkali dissolution and the acid dissolution to promote dissolution. Next, after dissolving the fibrous sponge, the fibrous sponge is neutralized, and the insoluble matter is removed by centrifugation or a filter cloth. Subsequently, the filtrate is treated with activated carbon to remove off-flavors and brown colors. At this stage, a clear viscous sponge protein lysate is obtained. Further, in the case of purifying the obtained protein lysate, salting out precipitation such as ammonium sulfate, precipitation using an organic solvent such as ethyl alcohol, methyl alcohol or acetone, gel filtration treatment, ion exchange resin treatment and the like are performed. It was found that the sponge-derived protein solution thus obtained can be used in a wide range of fields such as raw materials for foods, raw materials for pet foods, and raw materials for cosmetics and pharmaceuticals.

【0005】海綿動物加水分解物の製造法を説明する
と、海綿動物タンパク質溶解物は高分子であるため、高
濃度になると、粘性が非常に高くなり取り扱い難いの
で、タンパク質加水分解酵素で低分子化することが適当
である。このタンパク質加水分解酵素による分解は、上
記海綿動物タンパク質溶解物をタンパク質加水分解酵素
の基質として用いることにより、単に取り扱い上の間題
解決のみならず、低分子化により細胞賦活作用や抗癌作
用のある生理活性ペプチドやアミノ酸を得ることができ
る。また、基質である海綿動物タンパク質溶解物の濃度
は、特に限定されるものではないが、通常、濃度0.1
〜15重量%の範囲が好適である。タンパク質濃度が1
5重量%を越えるときは、後述のように加水分解反応に
おいて生成する反応産物を限外濾過膜や精密濾過膜で連
続的に分離する場合には、膜の目詰まりを助長してタン
パク質分解物は生産性を低下させる。他方、0.1重量
%より濃度の低いときは、反応産物の濃度が過度に低く
なるためにタンパク質分解物の濃縮に多大のエネルギー
と時間を必要とする。
A method for producing a sponge hydrolyzate is as follows. Since a sponge protein solution is a polymer, it becomes very viscous at a high concentration and becomes difficult to handle. It is appropriate to do so. Degradation by this protein hydrolase not only solves the problem of handling by using the above-mentioned sponge protein lysate as a substrate for the protein hydrolase, but also reduces cell activation and anti-cancer effects by reducing the molecular weight. A certain physiologically active peptide or amino acid can be obtained. Further, the concentration of the sponge protein lysate as a substrate is not particularly limited, but is usually 0.1%.
A range of 1515% by weight is preferred. 1 protein concentration
When the amount exceeds 5% by weight, when the reaction product generated in the hydrolysis reaction is continuously separated by an ultrafiltration membrane or a microfiltration membrane as described later, clogging of the membrane is promoted to promote protein degradation. Reduces productivity. On the other hand, when the concentration is lower than 0.1% by weight, the concentration of the reaction product becomes excessively low, so that a large amount of energy and time are required for concentration of the proteolysate.

【0006】本発明の方法において用いるタンパク質加
水分解酵素は、特に限定されるものではなく、一般には
動物、植物、あるいは微生物由来などのタンパク質加水
分解酵素が好ましく用いられる。目的に応じてエンド型
やエキソ型タンパク質加水分解酵素を単独で、あるいは
適当な比率で混合して用いることもできる。また、タン
パク質加水分解酵素が、遊離状態であるもの、タンパク
質加水分解酵素間で架橋されているもの、タンパク質加
水分解酵素が包括されたもの又はタンパク質加水分解酵
素が不溶性担体に固定化されているものを使用すること
も可能である。
[0006] The protein hydrolase used in the method of the present invention is not particularly limited, and generally, a protein hydrolase derived from animals, plants, or microorganisms is preferably used. Depending on the purpose, endo- or exo-type protein hydrolases can be used alone or in a mixture at an appropriate ratio. Further, those in which the protein hydrolase is in a free state, one in which the protein hydrolase is cross-linked, one in which the protein hydrolase is included, or one in which the protein hydrolase is immobilized on an insoluble carrier. It is also possible to use

【0007】さらには、本発明の方法において用いるタ
ンパク質加水分解酵素を不溶性担体に共有結合、イオン
結合、物理的吸着などの方法で固定化することができ
る。不溶性担体として、カルボキシメチルセルロース、
エチレン−マレイン酸共重合体、カルボキシクロリド樹
脂、カルボジイミド樹脂、アクリルアミド−メタクリル
酸共重合体、臭化シアン活性化多糖体、DEAE−セル
ロース、DEAE−Sephadex、Amberli
te類、活性炭、多孔性ガラス、酸性白土、シリカゲ
ル、アルミナ、ベントナイト、ポリスルホン、ポリアミ
ド、ポリイミド、ポリエーテルスルホン、酢酸セルロー
ス、ポリアクリロニトリルなどが挙げられる。
Further, the protein hydrolase used in the method of the present invention can be immobilized on an insoluble carrier by a method such as covalent bond, ionic bond, or physical adsorption. As an insoluble carrier, carboxymethyl cellulose,
Ethylene-maleic acid copolymer, carboxychloride resin, carbodiimide resin, acrylamide-methacrylic acid copolymer, cyanogen bromide-activated polysaccharide, DEAE-cellulose, DEAE-Sephadex, Amberli
Tes, activated carbon, porous glass, acid clay, silica gel, alumina, bentonite, polysulfone, polyamide, polyimide, polyethersulfone, cellulose acetate, polyacrylonitrile, and the like.

【0008】また、タンパク質加水分解酵素同士を架橋
したものを用いることができる。架橋剤として、グルタ
ルアルデヒド、イソシアネート誘導体、ビスジアゾベン
ジジン、N,N’−ポリメチレンビスヨードアセトアミ
ド、N,N’−エチレンビスマレインイミドなどを使
う。さらに、タンパク質加水分解酵素をポリマーのゲル
の格子の中に包み込んで脱離できない状態にして包括固
定化(格子型)する方法や半透明膜性のポリマーの皮膜
によって酵素を被覆し包括固定化(マイクロカプセル
型)することもできる。格子型として用いるポリマー
は、ポリアクリルアミドゲル、ポリビニールアルコール
ゲル、ケイ素樹脂、デンプンマトリックス、コンニュク
粉などが挙げられる。また、マイクロカプセル型のポリ
マーとして、ナイロン、ポリウレタン、エチルセルロー
ス、ポリスチレン、コロジオン、硝酸セルロース、ブチ
ル酢酸セルロース、ポリウレア、ポリアミドなどが挙げ
られる。
[0008] Further, those obtained by crosslinking protein hydrolases can be used. Glutaraldehyde, isocyanate derivatives, bisdiazobenzidine, N, N'-polymethylenebisiodoacetamide, N, N'-ethylenebismaleimide, etc. are used as the crosslinking agent. Furthermore, entrapping and immobilizing protein hydrolase in a matrix of polymer gel by encapsulating it in a state where it cannot be detached (lattice type) or coating the enzyme with a translucent polymer film ( (Microcapsule type). Examples of the polymer used as the lattice type include polyacrylamide gel, polyvinyl alcohol gel, silicon resin, starch matrix, konjac powder and the like. Examples of the microcapsule type polymer include nylon, polyurethane, ethyl cellulose, polystyrene, collodion, cellulose nitrate, cellulose butyl acetate, polyurea, and polyamide.

【0009】本発明で得られる乾燥海綿動物を溶解させ
た後、上澄み液をアルカリ溶液又は酸性溶液を使用して
中和して得られた海綿動物タンパク質溶液自体は、食品
用原料、ペットフ−フド用原料、化粧品又は医薬品並び
に哺乳類由来の細胞に対して増殖促進作用を有する。ま
た、得られた海綿動物タンパク質溶液にタンパク質加水
分解酵素を作用させて得られるタンパク質加水分解物も
海綿動物タンパク質溶液と同様の用途に供することがで
きる。このときに用いるタンパク質加水分解酵素は、そ
れ程の制限はなく、遊離状態であるもの、タンパク質加
水分解酵素間で架橋されているもの、タンパク質加水分
解酵素が包括されたもの、又は不溶性担体に固定化され
ているものなどを用いることができる。また、タンパク
質加水分解酵素は、エンド型又はエキソ型タンパク質加
水分解酵素を、それぞれ単独で、あるいは両者を適当な
比率で混合して用いることもできる。
[0009] The sponge protein solution itself obtained by dissolving the dried sponge obtained in the present invention and neutralizing the supernatant with an alkaline solution or an acidic solution is used as a raw material for food, pet food. It has a growth promoting effect on raw materials, cosmetics or pharmaceuticals, and mammalian cells. Further, a protein hydrolyzate obtained by allowing a protein hydrolase to act on the obtained sponge protein solution can also be used for the same uses as the sponge protein solution. The protein hydrolase used at this time is not particularly limited, and may be in a free state, a cross-linked state between protein hydrolases, a protein hydrolase included, or immobilized on an insoluble carrier. What has been done can be used. As the protein hydrolase, endo-type or exo-type protein hydrolase can be used alone or in a mixture of both at an appropriate ratio.

【0010】上述するように海綿動物タンパク質加水分
解物は、そのままでも食品、化粧品、医薬などに応用で
きるが、必要に応じて適宜の濃縮手段にて濃縮すること
ができる。濃縮手段としては、例えば、加熱蒸発法など
の一般的な手段も採用し得るが、逆浸透法によって、容
易且つ効率的に濃縮することができる。また、加水分解
物を上記のようにして適宣に濃縮した後、噴霧乾燥など
の手段によって粉末化することができる。さらには、ゲ
ル濾過、イオン交換樹脂、精密濾過膜又は限外濾過膜な
どの手段によって特異的な加水分解物の画分を得ること
により、より付加価値の高い食品、化粧品、医薬製品あ
るいは哺乳類由来の細胞に対して増殖促進作用を有する
用途に供することができる。
As described above, the sponge protein hydrolyzate can be applied to foods, cosmetics, medicines and the like as it is, but can be concentrated by an appropriate concentration means as needed. As a concentration means, for example, a general means such as a heating evaporation method can be adopted, but the concentration can be easily and efficiently performed by a reverse osmosis method. Further, after the hydrolyzate is appropriately concentrated as described above, it can be pulverized by means such as spray drying. Furthermore, by obtaining a specific hydrolyzate fraction by means such as gel filtration, ion exchange resin, microfiltration membrane or ultrafiltration membrane, it is possible to obtain foods, cosmetics, pharmaceutical products or mammal-derived products with higher added value. Can be used for applications having a growth promoting effect on cells.

【0011】[0011]

【実施例】以下に実施例を拳げて本発明を説明するが、
本発明はこれら実施例により何ら限定されるものではな
い。
The present invention will be described below with reference to examples.
The present invention is not limited by these examples.

【実施例1】乾燥した繊維性の海綿動物を細片にした
後、その細片物100gに20重量%の水酸化ナトリウ
ム水溶液900gを加え、50℃に加温して1時間攪拌
した。溶解確認後、30重量%の塩酸で中和し、濾過布
にて不溶残査を取り除いて上澄み液を得た。予め活性炭
を積層していたブフナーロートにその上澄み液を流し込
むことにより、上澄み液の色や臭いを除去した。この上
澄み液を直接、又は噴霧乾燥機で粉末化して強化・機能
性食品用原料やペットフード用原料として使用できた。
Example 1 A dried fibrous sponge was cut into small pieces, and 900 g of a 20% by weight aqueous sodium hydroxide solution was added to 100 g of the small pieces, and the mixture was heated to 50 ° C. and stirred for 1 hour. After confirming dissolution, the mixture was neutralized with 30% by weight of hydrochloric acid, and the insoluble residue was removed with a filter cloth to obtain a supernatant. The color and odor of the supernatant were removed by pouring the supernatant into a Buchner funnel on which activated carbon had been previously laminated. This supernatant liquid could be used directly or as a raw material for fortified and functional foods and a raw material for pet foods by pulverizing with a spray dryer.

【0012】[0012]

【実施例2】乾燥した繊維性の海綿動物を細片にした
後、その細片物100gに30重量%の水酸化カリウム
水溶液900gを加え、50℃に加温して1時間攪拌し
た。溶解確認後、30重量%の塩酸で中和し、遠心分離
にて不溶残査を取り除いて上澄み液を得た。この上澄み
液500gに対し活性炭−酸性白土混合物(50%−5
0%)を50g添加して30分間攪拌後、濾紙を用いて
濾過した。引き続きタンパク質精製のため、濾液をゲル
濾過にて篩い分けし、分子量約5万〜100万のタンパ
ク質画分を回収した後、逆浸透膜にて濃縮した。この濃
縮液をスムーザーなどでPETフィルム上に薄く塗工し
た後、乾燥し、海綿動物タンパク質薄膜を得た。得られ
た薄膜は医療用人口皮膚として使用可能であった。
Example 2 A dried fibrous sponge was cut into small pieces, and 100 g of the pieces were added with 900 g of a 30% by weight aqueous solution of potassium hydroxide, heated to 50 ° C., and stirred for 1 hour. After confirming dissolution, the mixture was neutralized with 30% by weight of hydrochloric acid, and the insoluble residue was removed by centrifugation to obtain a supernatant. An activated carbon-acid clay mixture (50% -5%) was added to 500 g of the supernatant.
(0%) was added, and the mixture was stirred for 30 minutes and then filtered using filter paper. Subsequently, for protein purification, the filtrate was sieved by gel filtration to collect a protein fraction having a molecular weight of about 50,000 to 1,000,000, and then concentrated with a reverse osmosis membrane. This concentrated solution was thinly coated on a PET film with a smoother or the like, and then dried to obtain a sponge protein thin film. The obtained thin film was usable as artificial skin for medical use.

【0013】[0013]

【実施例3】乾燥した繊維性の海綿動物を細片にした
後、その細片物1kgに20重量%の水酸化ナトリウム
水溶液9kgを加え、50℃に加温して1時間攪拌し
た。溶解確認後、30重量%の塩酸で中和し、遠心分離
にて不溶残査を取り除いて上澄み液を得た。この上澄み
液約10kgに対し活性炭を1kg添加して30分間攪
拌後、濾紙を用いて濾過した。引き続きこの海綿動物タ
ンパク質溶液を加水分解するために、微生物由来のエン
ド型及びエキソ型のタンパク質分解酵素を乾燥重量1g
(タンパク質溶液の乾燥重量を予め測定していく)当た
りそれぞれ500Uづつ添加し、50℃にて8時間反応
させた。尚、加水分解の反応状況を定期的にゲル濾過で
確認した。反応終了後、逆浸透膜にて脱塩し、反応生成
物を噴霧乾燥機で粉末化した。得られた粉末は、低分子
ペプチドやアミノ酸を含有する調味粉末として使用でき
た。
Example 3 After drying a dried fibrous sponge into small pieces, 9 kg of a 20% by weight aqueous sodium hydroxide solution was added to 1 kg of the small pieces, heated to 50 ° C., and stirred for 1 hour. After confirming dissolution, the mixture was neutralized with 30% by weight of hydrochloric acid, and the insoluble residue was removed by centrifugation to obtain a supernatant. Approximately 10 kg of the supernatant was added with 1 kg of activated carbon, stirred for 30 minutes, and filtered using filter paper. In order to subsequently hydrolyze the sponge protein solution, endo- and exo-type proteolytic enzymes derived from microorganisms were dried at 1 g dry weight.
Each 500 U was added per (the dry weight of the protein solution was measured in advance) and reacted at 50 ° C. for 8 hours. In addition, the reaction status of the hydrolysis was periodically confirmed by gel filtration. After completion of the reaction, the solution was desalted with a reverse osmosis membrane, and the reaction product was pulverized with a spray dryer. The obtained powder could be used as a seasoning powder containing low molecular weight peptides and amino acids.

【0014】[0014]

【実施例4】実施例3で得られた海綿動物タンパク質溶
液を加水分解するために、酵素遊離型メンブレンバイオ
リアクター装置を構築した。すなわち、基質タンクに海
綿動物タンパク質溶液1kgと微生物由来のエンド型タ
ンパク質分解酵素を乾燥重量1g(タンパク質溶液の乾
燥重量を予め測定しておく)当たり1000U添加した
後、ポンプで流速を0.10m/Sに調節し、基質タン
ク内の基質−酵素混合液温度が50℃になるまで循環さ
せた。温度上昇後、バルプで膜圧力を0.5kg/cm
2 に調節し、反応生成物を連続的に限外濾過膜(平均分
画分子量2万)で濾液として回収した。なお、濾液とし
て得られた量だけ基質タンクに海綿動物タンパク質溶液
をリザーバータンクより供給し、また2時間に一度タン
パク質分解酵素を乾燥重量1g(タンパク質溶液の乾燥
重量を予め測定しておく)当たり500U添加した。反
応終了後、逆浸透膜にて脱塩し、反応生成物を噴霧乾燥
機で粉末化した。使用結果を表1に示す。
Example 4 An enzyme-free membrane bioreactor was constructed to hydrolyze the sponge protein solution obtained in Example 3. That is, 1 kg of a sponge protein solution and 1 U of a microbial endoprotease are added to a substrate tank per 1 g of dry weight (the dry weight of the protein solution is measured in advance), and the flow rate is set to 0.10 m / p by a pump. The mixture was adjusted to S and circulated until the temperature of the substrate-enzyme mixture in the substrate tank reached 50 ° C. After the temperature rise, the membrane pressure is increased to 0.5 kg / cm
The mixture was adjusted to 2 , and the reaction product was continuously collected as a filtrate by an ultrafiltration membrane (average molecular weight cut-off: 20,000). In addition, the sponge animal protein solution is supplied from the reservoir tank to the substrate tank by the amount obtained as the filtrate, and 500 U per 1 g of dry weight of the protease is measured once every 2 hours (the dry weight of the protein solution is measured in advance). Was added. After completion of the reaction, the solution was desalted with a reverse osmosis membrane, and the reaction product was pulverized with a spray dryer. The results of use are shown in Table 1.

【0015】[0015]

【実施例5】実施例3で得られた海綿動物タンパク質溶
液を加水分解するために、実施例4の酵素遊離型メンブ
レンバイオリアクター装置の限外濾過膜の代わりに、タ
ンパク質分解酵素を予め膜内のスポンジ層にグルタルア
ルデヒドを用いて架橋法で固定化した限外濾過膜(酵素
固定化量:50U/cm2 −膜面積)を使用した。すな
わち、基質タンクに海綿動物タンパク質溶液1kgを添
加した後、ポンプで流速を0.11m/Sに調節し、基
質タンク内の基質溶液温度が50℃になるまで循環させ
た。温度上昇後、バルプで膜圧力を0.5kg/cm2
に調節し、反応生成物を連続的に酵素固定化限外濾過膜
(平均分画分子量1万)で濾液として回収した。尚、濾
液として得られた量だけ基質タンクに海綿動物タンパク
質溶液をリザーバータンクより供給した。反応終了後、
反応生成物である濾液を逆浸透膜にて脱塩し、噴霧乾燥
機で粉末化した。使用結果を表1に示す。
Example 5 In order to hydrolyze the sponge protein solution obtained in Example 3, instead of the ultrafiltration membrane of the enzyme-free membrane bioreactor of Example 4, a protease was previously introduced into the membrane. An ultrafiltration membrane (amount of enzyme immobilized: 50 U / cm 2 -membrane area) immobilized on the sponge layer of Example 1 by glutaraldehyde by a crosslinking method was used. That is, after adding 1 kg of the sponge protein solution to the substrate tank, the flow rate was adjusted to 0.11 m / S by a pump, and the solution was circulated until the temperature of the substrate solution in the substrate tank reached 50 ° C. After the temperature rises, the membrane pressure is increased to 0.5 kg / cm 2
The reaction product was continuously collected as a filtrate using an enzyme-immobilized ultrafiltration membrane (average molecular weight cut off: 10,000). The sponge protein solution was supplied from the reservoir tank to the substrate tank in an amount obtained as the filtrate. After the reaction,
The filtrate as a reaction product was desalted with a reverse osmosis membrane and powdered with a spray dryer. The results of use are shown in Table 1.

【0016】[0016]

【実施例6】実施例3で得られた梅綿タンパク質溶液を
加水分解するために、酵素固定型カラムバイオリアクタ
ー装置を構築した。すなわち、カラム内に充填している
イオン交換樹脂に予め微生物由来のエンド型及びエキソ
型のタンパク質分解酵素をイオン結合法で固定化した
(固定化量:エンド型20U/cm2 −イオン交換樹脂
表面積十エキソ型35U/cm2 −イオン交換樹脂表面
積)。反応は、ヒーターでカラム温度を45℃に調節
後、海綿動物タンパク質溶液の入った基質タンクから流
量10ml/minで基質溶液をカラムに供給した。な
お、反応生成物として得られた量だけ基質タンクに海綿
動物タンパク質溶液をリザーバータンクより連続的に供
給した。反応終了後、反応生成物を逆浸透膜にて脱塩
し、噴霧乾燥機で粉末化した。使用結果を表1に示す。
Example 6 An enzyme-immobilized column bioreactor was constructed to hydrolyze the plum wool protein solution obtained in Example 3. That is, endo-type and exo-type proteolytic enzymes derived from microorganisms were previously immobilized on the ion-exchange resin packed in the column by an ion binding method (immobilization amount: 20 U / cm 2 -end-exchange resin surface area of the end-type). 10 exo type 35 U / cm 2 -ion exchange resin surface area). In the reaction, after adjusting the column temperature to 45 ° C. with a heater, the substrate solution was supplied to the column at a flow rate of 10 ml / min from the substrate tank containing the sponge protein solution. The sponge protein solution was continuously supplied from the reservoir tank to the substrate tank in an amount obtained as a reaction product. After completion of the reaction, the reaction product was desalted with a reverse osmosis membrane and powdered with a spray dryer. The results of use are shown in Table 1.

【0017】[0017]

【実施例7】乾燥した繊維性の海綿動物を細片した後、
その細片物1.0kgに20.0重量%の塩酸水溶液9
kgを加え、85℃に加熱じて5時間攪拌した。溶解確
認後、20.0重量%の水酸化ナトリウムで中和し、遠
心分離にて不溶残査を取り除いて上澄み液を得た。この
上澄み液10kgに対し活性炭を1kg添加して30分
間攪拌後、濾紙を用いて濾過した。引き続きタンパク質
精製のため、濾液をゲル濾過にて飾い分けし分子量約5
000〜50万のタンパク質画分を回収した後、逆浸透
膜にて濃縮した。この濃縮液を噴霧乾燥機で粉末化し
た。実施例4〜7で得られた海綿動物タンパク質加水分
解物の粉末を化粧水用の薬液にそれぞれ添加した。対照
に、海綿動物タンパク質加水分解物の粉末無添加(減量
分をイオン交換水で置換)、コラーゲン添加区、シルク
タンパク質(セリシン)添加区、グリシン添加区も同時
に調製し、皮膚への使用感を調べた。使用結果を表1に
示す。
Example 7 After the dried fibrous sponge was cut into pieces,
A 20.0% by weight aqueous solution of hydrochloric acid 9 was added to 1.0 kg of the strips.
Then, the mixture was heated to 85 ° C. and stirred for 5 hours. After confirming dissolution, the mixture was neutralized with 20.0% by weight of sodium hydroxide, and the insoluble residue was removed by centrifugation to obtain a supernatant. 1 kg of activated carbon was added to 10 kg of the supernatant, stirred for 30 minutes, and then filtered using a filter paper. Subsequently, the filtrate was separated by gel filtration for protein purification, and the molecular weight was about 5%.
After collecting 000 to 500,000 protein fractions, they were concentrated with a reverse osmosis membrane. This concentrate was pulverized with a spray dryer. The sponge protein hydrolyzate powders obtained in Examples 4 to 7 were respectively added to a liquid for lotion. As controls, no sponge protein hydrolyzate powder was added (the weight loss was replaced with ion-exchanged water), collagen addition, silk protein (sericin) addition, and glycine addition were also prepared at the same time to improve the feeling of use on the skin. Examined. The results of use are shown in Table 1.

【0018】[0018]

【表1】 [Table 1]

【0019】表1の結果からみて、本発明の実施例4〜
7で得られた海綿動物タンパク質加水分解物は、従来、
化粧品原料として使用されているタンパク質やアミノ酸
を用いたときの処方(対照処方1〜4)に匹敵する使用
感が得られた。このことは本発明における材料費の経済
性を勘案すると、多大の効果が発揮されることが明らか
である。
According to the results shown in Table 1, Examples 4 to 4 of the present invention are shown.
The sponge protein hydrolyzate obtained in 7 is conventionally
A feeling of use comparable to the formulations (control formulations 1 to 4) using proteins and amino acids used as cosmetic raw materials was obtained. It is clear that a great effect is exhibited in consideration of the economical cost of the material in the present invention.

【0020】[0020]

【実施例8】実施例4〜7で得られた海綿タンパク質加
水分解の粉末、対照として実施例4〜7において活性炭
処理する前の海綿タンパク質及び加水分解コラ−ゲンを
用いて、ヒト由来の表皮角化細胞に対する増殖促進効果
について調べた。すなわち、ゲルダール法より得られた
窒素量から換算して、それぞれのタンパク質濃度を1.
0%に調節した。24wellの培養プレ−トに培地と
して2.0 のF−12培地(ヒドロコルチゾン・アデ
ニン・牛胎児血清を添加)、表皮角化細胞数を2×10
6 / 、海綿タンパク質を最終濃度0.003125〜
0.1%、30℃、5.0%CO2 の条件下で7日間培
養した。培養後、NTTアッセイ法により生細胞数をM
TT(3-[4,5-dimethylethiazol-2-yl]-2,5-diphenyltet
razoliumbromide) の色調変化(Optical Density : 570n
m - 650nm) から測定した。その結果を図1に示した
(実施例−4活性炭処理無のO.D.値を100%とし
て計算した)。コラーゲン添加区の場合、表皮角化細胞
の増殖に対し全く促進効果はなかったが、海綿タンパク
質では0.00625%以上の濃度で細胞増殖促進効果
を示した。
Example 8 Human-derived epidermis using the sponge protein hydrolyzed powder obtained in Examples 4 to 7 and the control as sponge protein and hydrolyzed collagen before activated carbon treatment in Examples 4 to 7 The growth promoting effect on keratinocytes was examined. That is, each protein concentration was calculated from the amount of nitrogen obtained by the Geldar method.
Adjusted to 0%. 2.0 wells of F-12 medium (hydrocortisone / adenine / fetal calf serum added) were added to a 24-well culture plate, and the number of keratinocytes was 2 × 10 5
6 /, the final concentration of sponge protein was 0.003125-
The cells were cultured under conditions of 0.1%, 30 ° C. and 5.0% CO 2 for 7 days. After the culture, the number of viable cells
TT (3- [4,5-dimethylethiazol-2-yl] -2,5-diphenyltet
razoliumbromide) (Optical Density: 570n
m-650 nm). The results are shown in Fig. 1 (Example-4: OD value without activated carbon treatment was calculated as 100%). In the case of the collagen-added group, there was no promoting effect on the proliferation of epidermal keratinocytes, but the sponge protein showed the promoting effect on cell proliferation at a concentration of 0.00625% or more.

【0021】[0021]

【発明の効果】本発明では、従来、身体の洗浄用や化粧
用などのスポンジとしてのみ使用され、削りカス部分に
ついては破棄処分されていた海綿動物スポンジを原料と
して、より付加価値の高い食品、ペットフ−ズ及び化粧
品・医薬などの原料である海綿動物タンパク質加水分解
物を得ることは社会的ニ−ズにジャストフィットするも
のである。さらに、本発明で得られた海綿動物タンパク
質加水分解物を精製処理することによって、一層経済性
の高い製品原料として利用でき、本発明の社会的有用性
はきわめて高いものである。
According to the present invention, a sponge sponge which has been conventionally used only as a sponge for body washing or cosmetics, and the shavings portion has been discarded, is used as a raw material to produce a high value-added food, Obtaining a sponge protein hydrolyzate that is a raw material for pet foods and cosmetics / medicines is a just fit for social needs. Furthermore, by purifying the sponge protein hydrolyzate obtained in the present invention, it can be used as a more economical product material, and the social utility of the present invention is extremely high.

─────────────────────────────────────────────────────
────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成11年4月8日(1999.4.8)[Submission date] April 8, 1999 (1999.4.8)

【手続補正1】[Procedure amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】図面の簡単な説明[Correction target item name] Brief description of drawings

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【図面の簡単な説明】[Brief description of the drawings]

【図1】 ヒト由来の表皮角化細胞の増殖に対する海面
タンパク質及び加水分解コラ−ゲンの影響
FIG. 1. Effect of sea surface protein and hydrolyzed collagen on the proliferation of human-derived epidermal keratinocytes

フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C07K 1/34 C07K 1/34 14/435 14/435 // A23J 1/04 A23J 1/04 3/04 3/04 3/34 3/34 A61K 7/00 A61K 7/00 K 38/00 A61L 27/00 C A61L 27/00 V A61K 37/18 (72)発明者 中村 興司 大阪府大阪市東淀川区西淡路6丁目3番41 号 中村物産株式会社淡路工場内 (72)発明者 岡田 猛 大阪府大阪市東淀川区西淡路6丁目3番41 号 中村物産株式会社淡路工場内 (72)発明者 三宅 忠雄 大阪府大阪市東淀川区西淡路6丁目3番41 号 中村物産株式会社淡路工場内Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat II (Reference) C07K 1/34 C07K 1/34 14/435 14/435 // A23J 1/04 A23J 1/04 3/04 3/04 3/34 3/34 A61K 7/00 A61K 7/00 K 38/00 A61L 27/00 C A61L 27/00 V A61K 37/18 (72) Inventor Koji Nakamura 6-3 Nishiawaji, Higashiyodogawa-ku, Osaka-shi, Osaka No. 41 Nakamura Bussan Co., Ltd. Awaji Plant (72) Inventor Takeshi Okada 6-3-3 Nishi Awaji, Higashiyodogawa-ku, Osaka City, Osaka Prefecture Nakamura Bussan Co., Ltd. Awaji Plant (72) Inventor Tadao Miyake Higashiyodogawa, Osaka City, Osaka Prefecture 6-41 Nishi-Awaji-ku Nakamura Bussan Awaji Plant

Claims (19)

【特許請求の範囲】[Claims] 【請求項1】 乾燥海綿動物を溶解させた後、上澄み液
を中和して得られた海綿動物タンパク質溶液。
1. A sponge protein solution obtained by dissolving a dried sponge and neutralizing the supernatant.
【請求項2】 濃度が、0.1〜15重量%の範囲であ
ることを特徴とする請求項1の海綿動物タンパク質溶
液。
2. The sponge protein solution according to claim 1, wherein the concentration is in the range of 0.1 to 15% by weight.
【請求項3】 食品用原料、ペットフ−ド用原料、化粧
品又は医薬品に用いることを特徴とする請求項1又は2
の海綿動物タンパク質溶液。
3. The composition according to claim 1, wherein the composition is used as a raw material for foods, a raw material for pet foods, cosmetics or pharmaceuticals.
Sponge protein solution.
【請求項4】 哺乳類由来の細胞に対して増殖促進作用
を有する用途に供することを特徴とする請求項1又は2
の海綿動物タンパク質溶液。
4. The method according to claim 1, wherein the cell is used for an application having a growth promoting effect on mammalian cells.
Sponge protein solution.
【請求項5】 乾燥海綿動物を溶解させた後、上澄み液
を中和して得られた海綿動物タンパク質溶液にタンパク
質加水分解酵素を作用させて得られる海綿動物タンパク
質加水分解物。
5. A sponge protein hydrolyzate obtained by dissolving a dried sponge, neutralizing the supernatant, and allowing a protein hydrolase to act on a sponge protein solution obtained.
【請求項6】 タンパク質加水分解酵素が、遊離状態で
あるもの、タンパク質加水分解酵素間で架橋されている
もの、タンパク質加水分解酵素が包括されたもの又はタ
ンパク質加水分解酵素が不溶性担体に固定化されている
ものであることを特徴とする請求項5の海綿動物タンパ
ク質加水分解物。
6. A protein hydrolase in a free state, a protein hydrolase cross-linked, a protein hydrolase inclusive, or a protein hydrolase immobilized on an insoluble carrier. The sponge protein hydrolyzate according to claim 5, characterized in that:
【請求項7】 タンパク質加水分解酵素が、エンド型又
はエキソ型タンパク質加水分解酵素を、それぞれ単独
で、あるいは両者を適当な比率で混合しているものであ
ることを特徴とする請求項5又は6のいずれかに記載の
海綿動物タンパク質加水分解物。
7. The protein hydrolase according to claim 5, wherein the endo- or exo-type protein hydrolase is used alone or in a mixture of both at an appropriate ratio. A sponge protein hydrolyzate according to any one of the above.
【請求項8】 食品用原料、ペットフ−ド用原料、化粧
品又は医薬品に用いることを特徴とする請求項5乃至7
のいずれかに記載の海綿動物タンパク質加水分解物。
8. The composition according to claim 5, which is used as a raw material for foods, a raw material for pet foods, cosmetics or pharmaceuticals.
A sponge protein hydrolyzate according to any one of the above.
【請求項9】 哺乳類由来の細胞に対して増殖促進作用
を有する用途に供することを特徴とする請求項5乃至8
のいずれかに記載の海綿動物タンパク質加水分解物。
9. The method according to claim 5, wherein the cell is used for an application having a growth promoting effect on mammalian cells.
A sponge protein hydrolyzate according to any one of the above.
【請求項10】 請求項5乃至9のいずれかに記載の海綿
動物タンパク質加水分解物を限外濾過膜、精密濾過膜、
ゲル濾過又はイオン交換樹脂を用いて得られる機能性低
分子ペプチド及び/又はアミノ酸。
10. The sponge protein hydrolyzate according to claim 5, comprising an ultrafiltration membrane, a microfiltration membrane,
Functional low molecular weight peptides and / or amino acids obtained using gel filtration or ion exchange resins.
【請求項11】 食品用原料、ペットフ−ド用原料、化粧
品又は医薬品に用いることを特徴とする請求項10に記載
の機能性低分子ペプチド及び/又はアミノ酸。
11. The functional low-molecular-weight peptide and / or amino acid according to claim 10, wherein the functional low-molecular-weight peptide and / or amino acid is used as a raw material for food, a raw material for pet food, a cosmetic or a pharmaceutical.
【請求項12】 哺乳類由来の細胞に対して増殖促進作用
を有する用途に供することを特徴とする請求項10に記載
の機能性低分子ペプチド及び/又はアミノ酸。
12. The functional low-molecular-weight peptide and / or amino acid according to claim 10, wherein the functional low-molecular-weight peptide and / or amino acid is used for an application having a growth promoting effect on mammalian cells.
【請求項13】 乾燥海綿動物を溶解させ、その上澄み液
を中和して得られた海綿動物タンパク質溶液にタンパク
質加水分解酵素を作用させることからなる海綿動物タン
パク質加水分解物の製造方法。
13. A method for producing a sponge protein hydrolyzate, comprising dissolving a dried sponge animal and neutralizing a supernatant thereof, and allowing a protein hydrolase to act on a sponge protein solution obtained.
【請求項14】 乾燥海綿動物の溶解液として、アルカリ
溶液又は酸性溶液を使用することを特徴とする請求項13
の海綿動物タンパク質加水分解物の製造方法。
14. The method according to claim 13, wherein an alkaline solution or an acidic solution is used as a solution for the dried sponge.
A method for producing a sponge protein hydrolyzate.
【請求項15】 乾燥海綿動物のアルカリ溶液又は酸性溶
液の濃度が、0.01〜15重量%であることを特徴と
する請求項13又は14に記載の海綿動物タンパク質加水分
解物の製造方法。
15. The method for producing a sponge protein hydrolyzate according to claim 13, wherein the concentration of the alkaline solution or the acidic solution of the dried sponge is 0.01 to 15% by weight.
【請求項16】 タンパク質加水分解酵素が、遊離状態の
もの、タンパク質加水分解酵素間で架橋されているも
の、タンパク質加水分解酵素が包括されたもの、又は不
溶性担体に固定化されているものを用いることを特徴と
する請求項13乃15のいずれかに記載の海綿動物タンパク
質加水分解物の製造方法。
16. Use of a protein hydrolase in a free state, a protein hydrolase cross-linked, a protein hydrolase inclusive, or a protein hydrolase immobilized on an insoluble carrier. The method for producing a sponge protein hydrolyzate according to any one of claims 13 to 15, wherein:
【請求項17】 タンパク質加水分解酵素が、エンド型又
はエキソ型タンパク質加水分解酵素を、それぞれ単独
で、あるいは両者を適当な比率で混合して用いることを
特徴とする請求項13乃至16のいずれかに記載の海綿動物
タンパク質加水分解物の製造方法。
17. The protein hydrolase according to claim 13, wherein an endo-type or exo-type protein hydrolase is used alone or in a mixture of both at an appropriate ratio. The method for producing a sponge protein hydrolyzate according to item 1.
【請求項18】 請求項13乃至17のいずれかに記載の海綿
動物タンパク質加水分解物を限外濾過膜、精密濾過膜、
ゲル濾過又はイオン交換樹脂を用いて機能性低分子ペプ
チド及び/又はアミノ酸を分離することを特徴とする機
能性低分子ペプチド及び/又はアミノ酸の製造方法。
An ultrafiltration membrane, a microfiltration membrane, or a sponge protein hydrolyzate according to any one of claims 13 to 17,
A method for producing a functional low-molecular peptide and / or amino acid, comprising separating a functional low-molecular peptide and / or amino acid using gel filtration or an ion exchange resin.
【請求項19】 原料として、破棄処分対象の乾燥海綿動
物の切断細片を使用することを特徴とする請求項13乃至
18のいずれかに記載の海綿動物タンパク質の製造方法。
19. The cut material of a dried sponge to be discarded is used as a raw material.
19. The method for producing a sponge protein according to any one of 18.
JP11010702A 1998-06-01 1999-01-19 Sponge animal protein hydrolyzate and method for producing the same Expired - Fee Related JP3094090B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11010702A JP3094090B2 (en) 1998-06-01 1999-01-19 Sponge animal protein hydrolyzate and method for producing the same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10-165865 1998-06-01
JP16586598 1998-06-01
JP11010702A JP3094090B2 (en) 1998-06-01 1999-01-19 Sponge animal protein hydrolyzate and method for producing the same

Publications (2)

Publication Number Publication Date
JP2000053696A true JP2000053696A (en) 2000-02-22
JP3094090B2 JP3094090B2 (en) 2000-10-03

Family

ID=26346024

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11010702A Expired - Fee Related JP3094090B2 (en) 1998-06-01 1999-01-19 Sponge animal protein hydrolyzate and method for producing the same

Country Status (1)

Country Link
JP (1) JP3094090B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1142904A1 (en) * 2000-04-04 2001-10-10 Kenji Nakamura Sponge protein hydrolysates and methods of producing the same
JP2007521238A (en) * 2002-07-01 2007-08-02 マリア ビラーニ, Sponge-based therapeutic compositions for the treatment and prevention of skin diseases
JP2008500040A (en) * 2004-05-26 2008-01-10 ノルケープ バイオテクノロジー エーエス Marine protein hydrolysates, their production methods and applications.
JP2010184941A (en) * 2010-06-01 2010-08-26 Maria Villani Sponge-based therapeutic composition for treating and preventing dermatosis
CN103202383A (en) * 2013-05-07 2013-07-17 山东瀚龙生物科技有限公司 Ready-to-eat fish meat protein power and preparation method thereof
KR101728125B1 (en) 2015-10-15 2017-04-19 (주)비엔 Method for manufacturing cosmetic composition containing porifera spicule
KR101851742B1 (en) * 2017-01-16 2018-04-24 주식회사 뷰렌코리아 Cosmetic composition containing porifera spicule coated with sawhangsan and method for manufacturing the same

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101676796B1 (en) * 2015-03-25 2016-11-16 제너럴바이오(주) A method for manufacturing of sponge powder having acicular structure and a sponge powder having acicular structure manufactured therefrom

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1142904A1 (en) * 2000-04-04 2001-10-10 Kenji Nakamura Sponge protein hydrolysates and methods of producing the same
US7429561B2 (en) 2000-04-04 2008-09-30 Kenji Nakamura And Koji Nakamura Method for stimulating cell growth using sponge protein hydrolysates
JP2007521238A (en) * 2002-07-01 2007-08-02 マリア ビラーニ, Sponge-based therapeutic compositions for the treatment and prevention of skin diseases
JP2008500040A (en) * 2004-05-26 2008-01-10 ノルケープ バイオテクノロジー エーエス Marine protein hydrolysates, their production methods and applications.
JP4807593B2 (en) * 2004-05-26 2011-11-02 ノルケープ バイオテクノロジー エーエス Marine protein hydrolysates, their production methods and applications.
JP2010184941A (en) * 2010-06-01 2010-08-26 Maria Villani Sponge-based therapeutic composition for treating and preventing dermatosis
CN103202383A (en) * 2013-05-07 2013-07-17 山东瀚龙生物科技有限公司 Ready-to-eat fish meat protein power and preparation method thereof
KR101728125B1 (en) 2015-10-15 2017-04-19 (주)비엔 Method for manufacturing cosmetic composition containing porifera spicule
KR101851742B1 (en) * 2017-01-16 2018-04-24 주식회사 뷰렌코리아 Cosmetic composition containing porifera spicule coated with sawhangsan and method for manufacturing the same

Also Published As

Publication number Publication date
JP3094090B2 (en) 2000-10-03

Similar Documents

Publication Publication Date Title
CN102533913B (en) Method for preparing antioxidant active peptide by hydrolyzing fish scale collagen with co-immobilized double enzymes
KR100977744B1 (en) Collagen and its production method
CN103789381B (en) A kind of method of Isin glue collagen rapid extraction
JP3094090B2 (en) Sponge animal protein hydrolyzate and method for producing the same
CN109371092A (en) A kind of preparation method of collagen peptide
JP4437237B2 (en) Method for producing useful composition
CN102228125B (en) Preparation method of algal active peptide
JP2000001499A (en) Peptide having biological activity, its use and its production
CN109293766A (en) The method of collagen polypeptide is extracted from fish scale
WO2015167003A1 (en) Collagen or atelocollagen hydrolysate, production method for said hydrolysate, and use for said hydrolysate
WO2015167004A1 (en) Composition for inducing differentiation
US7429561B2 (en) Method for stimulating cell growth using sponge protein hydrolysates
JPH05227983A (en) Production of peptide from rice bran protein
JP2004149736A (en) Chondroitin sodium sulfate, chondroitin sulfate-containing substance, and method for producing them
JP2004339189A (en) Extraction and utilization of cell growth peptide from silk protein
CN102277405A (en) Preparation method of snakeskin active peptide
CN110387397B (en) Preparation method of sheep skin collagen oligopeptide
CN104628844A (en) Soluble collagen and preparation method thereof
CN107338277A (en) A kind of method that ultrasonication wheat gluten prepares high F value oligopeptide
JP3437738B2 (en) Method for producing protein hydrolyzate with reduced odor
KR0144014B1 (en) Functional Silk Amino Acids and Manufacturing Method Thereof
CN109055471A (en) A kind of preparation method of crocodile ossein
CN1814782A (en) Method for extracting small molecule collagen protein from fish scale utilizing enzyme engineering technique
WO2005092960A1 (en) Biocompatible porous material and process for producing the same
JP2002281935A (en) Shark cartilage extract and method for producing the same

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080804

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080804

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090804

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090804

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100804

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110804

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110804

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120804

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120804

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130804

Year of fee payment: 13

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees